Related references
Note: Only part of the references are listed.Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
Vincenzo Carafa et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2011)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
William H. Chappell et al.
ONCOTARGET (2011)
IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer
Zhi Liu et al.
CLINICAL CANCER RESEARCH (2010)
The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
M. Hingorani et al.
CURRENT CANCER DRUG TARGETS (2010)
Targeting the PI3K signaling pathway in cancer
Kwok-Kin Wong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Emerging MEK inhibitors
James A. McCubrey et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
Peng Hou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Histone acetylation Where to go and how to get there
Vicki E. MacDonald et al.
EPIGENETICS (2009)
Induction of Thyroid Gene Expression and Radioiodine Uptake in Melanoma Cells: Novel Therapeutic Implications
Peng Hou et al.
PLOS ONE (2009)
Sodium/iodide symporter expression in primary lung cancer and comparison with glucose transporter 1 expression
Do Y. Kang et al.
PATHOLOGY INTERNATIONAL (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor
Wei Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Human melanoma cells express functional receptors for thyroid-stimulating hormone
Julie A. Ellerhorst et al.
ENDOCRINE-RELATED CANCER (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors
C Puppin et al.
ENDOCRINOLOGY (2005)
Expression of sodium iodide symporter in the lacrimal drainage system:: Implication for the mechanism underlying nasolacrimal duct obstruction in I131-treated patients
Kenneth E. Morgenstern et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor
R Zarnegar et al.
SURGERY (2002)
Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin
A Slominski et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
The sodium iodide symporter: its pathophysiological and therapeutic implications
C Spitzweg et al.
CLINICAL ENDOCRINOLOGY (2002)
Expression of the sodium iodide symporter in human kidney
C Spitzweg et al.
KIDNEY INTERNATIONAL (2001)
The mammary gland iodide transporter is expressed during lactation and in breast cancer
UH Tazebay et al.
NATURE MEDICINE (2000)
Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
T Kogai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas
HJ Park et al.
THYROID (2000)
Share Paper
